This is not the document you are looking for? Use the search form below to find more!

Report home > Health & Fitness

The Drug Development Process - From R&D to Commercialization

0.00 (0 votes)
Document Description
In today's fast-paced, highly regulated and risk-aversive environment, functional groups can no longer work in isolation, but must collaborate extensively to design, develop, manufacture, test, validate and commercialize new drugs. Successful commercialization depends on effective processes to bring both the drug supply manufacturing processes and controls as well as the associated data and knowledge to the levels required for an approvable launch.
File Details
Submitter
  • Username: globalpanel
  • Name: globalpanel
  • Documents: 232
Embed Code:

Add New Comment




Related Documents

The Drug Development Process - From R&D to Commercialization

by: davidross759, 2 pages

In today's fast-paced, highly regulated and risk-aversive environment, functional groups can no longer work in isolation, but must collaborate extensively to design, develop, manufacture, test, ...

Leader in software R&D services Announces Shashank Samant as New CEO

by: globallogic, 2 pages

GlobalLogic, a leader in software R&D services, today announced that Peter Harrison is stepping down as chief executive officer and that the board of directors has named Shashank Samant, ...

R&D - job proposal

by: Favio, 1 pages

job in lyon - R&D

The Role of Lab Data in the Drug Development Process: Adverse Events Subject Safety

by: martinlurthur, 2 pages

All Clinical Research protocols have a prominent safety monitoring "plan" as part of the overall research plan / protocol. This "plan" is to ensure the safety of participating subjects and to ensure ...

Time for India R&D centers to maximize value from Globalization: Says Zinnov

by: patrick1gall, 2 pages

(1888PressRelease) Zinnov-Adobe R&D Leadership Meet witnessed some very interesting perspectives from R&D leaders.

Distributed Agile Development- Collaborating with R&D teams worldwide

by: globallogic, 2 pages

Today’s global business environment has placed organization’s workforce and development teams across locations and time zones. However, the technological innovations have paved way for a ...

FDA Regulatory Control of the Drug Development Process and Investigator Responsibility in the Process

by: martinlurthur, 2 pages

When the PI signs the FDA form 1572 (for IND studies) or the "Statement of the Investigator (for IDE studies), she / he is signing a legally binding document committing themselves to follow all of ...

Drug Discovery New Drug Development Process

by: christian, 55 pages

DRUG DISCOVERY – NEW DRUG DEVELOPMENT PROCESS BY Dr. BASAVARAJ K. NANJWADE Department of Pharmaceutics K L E  UNIVERSITY JN MEDICAL COLLEGE BELGAUM – 590010 E-mail: bknanjwade@yahoo ...

China VAT : Understanding the Eligibility for VAT Incentives in R&D Centers

by: nair & co., 2 pages

China has provided clarification on certain Value Added Tax (VAT) incentives for purchase of equipment by foreign-funded Research and Development (R&D) centers. In a recent circular, authorities ...

For The First Time In Six Years, Global R&D Spending Decreases: Zinnov Study

by: patrick1gall, 2 pages

(1888PressRelease) Companies headquartered in APAC were the only ones to increase their R&D spending.

Content Preview


Live Webinar on

The Drug Development Process - From R&D to Commercialization


Course "The Drug Development Process - From R&D to
Commercialization" has been pre-approved by RAPS as eligible

Register Now

for up to 1.00 credits towards a participant's RAC recertification
upon full completion.
Date & Time:
Instructor Profile:
Thursday, July 12, 2012
10:00 AM PDT | 01:00 PM EDT
Amnon Eylath
Duration: 60 Minutes
Instructor: Amnon Eylath
Director Global Quality, Ariad
Pharmaceuticals
Location: Online
Price : $245.00 (for one participant)
Amnon Eylath is Director of Quality
at Ariad in Cambridge,
Overview:
Massachusetts. He is responsible for
In today's fast-paced, highly regulated and risk-aversive
global oversight of the QA/QC
environment, functional groups can no longer work in isolation, but
aspects of Drug Substance and Drug
must collaborate extensively to design, develop, manufacture, test,
Product Manufacturing, Testing,
Stability, Packaging and Distribution,
validate and commercialize new drugs. Successful commercialization
as well as oversight of compliance
depends on effective processes to bring both the drug supply
for Pre-Clinical (GLP) and Clinical
manufacturing processes and controls as well as the associated data
(GCP) Studies. Amnon has over 20
and knowledge to the levels required for an approvable launch.
years of experience in medical
research, process & method
An overview of the drug development process, reviewing key
development, device development,
deliverables for each stage of the development path with a special
facility/process design and
focus on managing the development process when using external
validation, GxP audits and regulatory
compliance, CMC support,
resources such as Contract Manufactures, Contract Testing Labs and
development and deployment of
Contract Research Organizations.
quality systems, as well as
disposition of Biotech and Small
Why Should You Attend:
Molecule clinical materials for US and
international use. ...more
How familiar are you with the complex and cross-functional activities
that make up the drug development path? If you are involved in any
step of drug development from discovery research through process
Suggest a Topic
More Webinars
development, pre-clinical and toxicological testing, GMP
manufacturing, clinical trials and regulatory affairs, an understanding

Your Necessity is our Priority
of how your role fits in with the other activities is key to achieving
effective and efficient development and commercialization.
Areas Covered in the Session:

l
The transition from discovery to development
l
The purpose of Pre-clinical studies
l
The four major clinical phases (1-4) in the drug development
process and the rationale for each with key deliverables
l
Milestones on The "Dual Path" to Drug Commercialization
l
Where do IND and NDA fit into the process
l
Overview of the key government regulations that impact the
development process (Code of Federal Regulations and ICH)
l
Designing the drug with the patient and regulations in mind
l
The criticality of effective project management for cross-
functional teams during the development process with special
focus on managing activities performed by contract
manufactures, labs and suppliers
Click here to register for this webinar
Who Will Benefit:
l
Research & development scientists
l
Clinical monitors and research associates
l
Medical and clinical investigators and study coordinators
l
Statisticians & data management professionals
l
CMC/pharmaceutical research professionals
l
Regulatory Affairs Professionals
l
Project Managers
l
Senior sales managers
l
Analytical Development

l
Program Management
It would be really nice if you can circulate this mail to all your deserving colleagues who can immensely
benefit from this program.

For more information, please contact the event coordinator. We look forward to seeing you at the webinar.
Best regards,
Event-coordinator
GlobalCompliancePanel
About GlobalCompliancePanel
GlobalCompliancePanel is an online knowledge fulfillment community portal & it has put together a new model for online
compliance training by creating a single window of learning opportunities for compliance professionals & providing a
forum for expert speakers/panelists to render their services through simplified online training delivery mechanisms. Our
commitment is give compliance regulatory training, showcasing of best industry practices & quality enrichment training
sessions in a most cost effective manner. Compliance professionals can benefit from a wide range of training sessions,
giving a diverse choice of events & all sessions being either Live or recorded stream or in the form of audio CDs.
GlobalCompliancePanel portal ensures a secure & cost effective online environment and also support your E-learning
and development on/through our website. Keep track of all webinars arranged for your industry through notifications &
event calendars being mailed to your inbox. GlobalCompliancePanel opens new doors of learning opportunities for
professionals.
GlobalCompliancePanel
www.globalcompliancepanel.com
1000 N West Street Suite,
1200 Wilmington DE 19801
Phone: 800-447-9407 or
Fax your PO to: 302-288-6884
If you do not wish to receive this training alerts from GlobalCompliancePanel Click Unsubscribe

Download
The Drug Development Process - From R&D to Commercialization

 

 

Your download will begin in a moment.
If it doesn't, click here to try again.

Share The Drug Development Process - From R&D to Commercialization to:

Insert your wordpress URL:

example:

http://myblog.wordpress.com/
or
http://myblog.com/

Share The Drug Development Process - From R&D to Commercialization as:

From:

To:

Share The Drug Development Process - From R&D to Commercialization.

Enter two words as shown below. If you cannot read the words, click the refresh icon.

loading

Share The Drug Development Process - From R&D to Commercialization as:

Copy html code above and paste to your web page.

loading